Krejcy Kurt

Krejcy Kurt has held various positions in the pharmaceutical industry, including Chief Medical Officer at AOP Orphan Pharmaceuticals AG since 2017. Prior to that, krejcy served as Head International Medical Affairs at the same company in 2016. Kurt also has extensive experience as the Medical Director Oncology Europe at Eli Lilly from 1995 to 2015.